In this study, we investigated the tumor suppressor role of Prkn, on the backdrop of a previously established GEMM system targeting premalignant (PM) NSCs to deplete major tumor suppressors Trp53 and Pten (Shingu et al., 2017). Here, PRKN is linked to neoplasm.